ARCHIVES

Approval Granted For New Formulation of Lupron Depot

This article is from The Cancer Letter archive.

Vol. 34 No. 7 | July 29, 2011

Download PDF Visit The Full Archive

Related Articles

“Harm-Reduction” Products No Proven, IOM Report Says.

March 2, 2001

Recommendations For Adjuvant Therapy In Breast Cancer

September 20, 1985

Turmoil in Texas: SEC Issues Subpoena to AVEO on Tivozanib

July 12, 2013

In Brief: Fredrickson Will Stay As NIH Director; NCI Group to Study Rhoads’ Clinical Center Idea

February 11, 1977

NCI audit Verifies Accuracy Of NSABP’s Lumpectomy Trial, B-06; Finds No Evidence Of Misrepresentation

October 21, 1994

FDA Concerned About Data-Dredging In Drug-Diagnostic Applications

January 30, 2009